Reaction
Chronic Hepatitis C reporting signals
As of the last recalculation, Chronic Hepatitis C appears in 390 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is SOFOSBUVIR (PRR 78.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sofosbuvir | 27 | 78.4 | 78.5 |
| Glecaprevir And Pibrentasvir | 11 | 55.0 | 55.0 |
| Inclisiran | 8 | 54.3 | 54.4 |
| Acetylcysteine | 9 | 52.1 | 52.2 |
| Ribavirin | 53 | 50.8 | 50.8 |
| Raltegravir | 15 | 50.4 | 50.4 |
| Lopinavir And Ritonavir | 12 | 48.7 | 48.8 |
| Velpatasvir And Sofosbuvir | 8 | 33.9 | 34.0 |
| Ritonavir 100 Mg | 9 | 32.9 | 32.9 |
| Atazanavir | 8 | 30.3 | 30.3 |
| Methadone | 20 | 26.2 | 26.2 |
| Dolutegravir Sodium | 4 | 23.9 | 23.9 |
| Ledipasvir And Sofosbuvir | 8 | 22.6 | 22.7 |
| Peginterferon Alfa-2A | 18 | 18.6 | 18.6 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 13 | 15.7 | 15.7 |